dihexa pnb-0408 c-met hgfr activator (PNB-0408) | C27H44N4O5 | CID 125355097 DIHEXA | HGF Mimetic Hexapeptide,
DIHEXA HGF Mimetic Hexapeptide, Lab Tested Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




